Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Domark International Inc.Financial_Report.xls
EX-31.2 - CERTIFICATION - Domark International Inc.domk_ex312.htm
EX-32.2 - CERTIFICATION - Domark International Inc.domk_ex322.htm
EX-31.1 - CERTIFICATION - Domark International Inc.domk_ex311.htm
EX-32.1 - CERTIFICATION - Domark International Inc.domk_ex321.htm

 

U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended November 30th, 2014

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT

 

For the transition period from ____________ to ____________

 

Commission File No. 000-55099

 

Domark International, Inc.

(Name of small business issuer as specified in its charter)

 

Nevada

 

20-4647578

(State of Incorporation)

 

(IRS Employer Identification No.)

 

34 King Street, East

Suite 1102

Toronto, Ontario M5C1E9

(416) 400-4421 

(Issuer's telephone number)

 

Securities registered under Section 12(b) of the Exchange Act:

 

None

 

Securities registered under Section 12(g) of the Exchange Act:

 

Common Stock, $0.001 par value per share 

(Title of Class)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation ST (ss.232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a nonaccelerated filer or a smaller reporting company.

 

Large accelerated filer

¨ 

Accelerated filer 

¨

Nonaccelerated filer

¨

Smaller reporting company

x

 

Indicate by check mark whether the registrant is a shell company (as defined in rule 12b2 of the Exchange Act) Yes ¨ No x

 

As of November 30, 2014, there were 5,624,995,392 shares of Common Stock, $0.001 par value per share, issued and outstanding and there were 50,000 shares of Series A Preferred Stock, $0.001 par value per share, issued and outstanding and there are zero shares of Series B Preferred Stock, $0.001 par value per share, issued and outstanding.

 

 

 

 

DOMARK INTERNATIONAL, INC.

 

TABLE OF CONTENTS 

 

PART I FINANCIAL INFORMATION

  PAGE  

 

   

Item 1.

Consolidated Financial Statements   3  

Consolidated Balance Sheets November 30, 2014 (unaudited) and May 31, 2014

  3-4  

Consolidated Statements of Operations three and six months ending November 30, 2014 and November 30, 2013 (unaudited)

 

5

 

Consolidated Statements of Cash Flows six months ending November 30, 2014 and November 30,, 2013 (unaudited) and

   

6

 

Notes to Consolidated Financial Statements (unaudited)

   

7

 
       

Item 2.

Management Discussion & Analysis of Financial Condition and Results of Operations

   

19

 
       

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

   

20

 
       

Item 4.

Controls and Procedures

   

20

 

 

PART II OTHER INFORMATION  

 

Item 1.

Legal Proceedings

  21  

 

   

Item 1A.

Risk Factors

   

21

 

 

       

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

   

21

 

 

       

Item 3.

Defaults Upon Senior Securities

   

21

 

 

       

Item 4.

Mine Safety Disclosure

   

21

 

 

       

Item 5.

Other information

   

21

 

 

       

Item 6.

Exhibits

   

22

 

 

 
2

 

PART I – CONSOLIDATED FINANCIAL INFORMATION

 

ITEM 1 – CONSOLIDATED FINANCIAL STATEMENTS

 

DOMARK INTERNATIONAL, INC.

 CONSOLIDATED BALANCE SHEETS

 

ASSETS

 

      November 30,     May 31,  
     

2014

   

2014

 
     

( Unaudited )

       
               

CURRENT ASSETS

           
 

Cash and cash equivalents

 

$

-

   

$

460

 
 

Loan receivable from consultant

   

36,203

     

36,203

 
 

Prepaid expenses

   

4,500

     

4,500

 
 

TOTAL CURRENT ASSETS

   

40,703

     

41,163

 
                   

INVESTMENTS

   

1,144,166

     

1,144,166

 
                   

OTHER ASSETS

               
 

Patents, net of accumulated amortization of $8,605 and $3,605, respectively

   

61,897

     

66,897

 
 

Licenses, net of accumulated amortization of $162,618 and $60,898 respectively

   

147,382

     

249,102

 
 

TOTAL OTHER ASSETS

   

209,279

     

315,999

 
                   

TOTAL ASSETS

 

$

1,394,148

   

$

1,501,328

 

  

See notes to interim consolidated financial statements.

 

 
3

 

DOMARK INTERNATIONAL INC.

CONSOLIDATED BALANCE SHEETS

 

LIABILITIES AND STOCKHOLDERS’ (DEFICIT)

 

    November 30,     May 31,  
   

2014

   

2014

 
   

( Unaudited )

       
                   

CURRENT LIABILITIES

               
 

Bank overdraft

 

$

18

   

$

-

 
 

Note payable to bank

   

180,000

     

180,000

 
 

Accounts payable and accrued expenses

   

61,765

     

56,940

 
 

Amounts due under Licensing Agreement with Wazzamba SA

   

224,924

     

224,925

 
 

Loans payable to consultants and stockholders

   

181,328

     

188,972

 
 

Convertible notes payable (net of unamortized discounts of $526,993 and $674,886 respectively)

   

140,044

     

67,414

 
 

Derivative liability for convertible notes payable

   

2,416,159

     

1,748,982

 
 

TOTAL CURRENT LIABILITIES AND TOTAL LIABILITIES

   

3,204,238

     

2,467,233

 
                   

STOCKHOLDERS’ DEFICIT

               
 

Preferred stock, $0.001 par value, authorized 10,000,000 shares:

               
 

Series A convertible preferred stock – issued and outstanding

               
 

50,000 shares as of November 30, 2014 & May 31, 2014

   

50

     

50

 
 

Convertible preferred stock series B, $0.0001 par value,

               
 

Authorized: 10,000,000

   

-

     

-

 
 

Common stock, $0.001 par value, authorized 7,500,000,000 shares:

               
 

5,749,811,000 and 801,627,000 shares issued,

               
 

and 5,749,811,000 and 801,627,000 shares outstanding,

               
 

as of November 30, 2014 & May 31, 2014

   

5,749,811

     

801,627

 
                   
 

Less: Treasury stock (124,819,802 shares) as of November 30, 2014 and May 30, 2014

   

(124,820

)

   

(124,820

)

 

Common stock payable

   

858,000

     

858,000

 
 

Additional paid in capital

   

39,176,795

     

43,529,923

 
 

Accumulated other comprehensive income (loss)

   

(112,240

)

   

(88,551

)

 

Accumulated deficit

   

(47,357,686

)

   

(45,942,134

)

                   
 

TOTAL STOCKHOLDERS’ DEFICIT

   

(1,810,090

)

   

(965,905

)

                   

TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT

 

$

1,394,148

   

$

1,501,328

 

  

See notes to interim consolidated financial statements.

 

 
4

 

DOMARK INTERNATIONAL, INC

CONSOLIDATED STATEMENTS OF OPERATIONS 

(Unaudited)

 

    For the three     For the three     For the six     For the six  
    Months     months     months     months  
    Ending     ending     ending     ending  
    November 30,     November 30,     November 30,     November 30,  
    2014     2013     2014     2013  
                 

Sales

 

$

-

   

$

-

   

$

-

   

$

-

 

Cost of sales

               

Gross profit

               
                 

Operating expenses:

               

General and administrative

 

32,163

   

259,559

   

241,806

   

519,002

 

Stock-based compensation - Consultants

   

0

     

59,850

     

55,620

     

513,675

 

Stock-based compensation - Salaries and wages

   

0

     

55,350

      -      

-

 

Depreciation and amortization expense

   

53,360

     

360

     

106,720

     

720

 

Total operating expenses

   

85,523

     

319,769

     

404,146

     

1,033,397

 
                               

Loss from operations

 

(85,523

)

 

(319,769

)

 

(427,835

)

 

(1,033,397

)

                               

Other income (expense):

                               

Other income

    -       -       -        

Revaluation of derivative liability for convertible notes

 

(474,291

)

 

(176,720

)

 

(667,181

)

 

(161,744

)

Interest expense

 

(196,797

)

 

(23,045

)

 

(344,230

)

 

(88,003

)

Total other income (expense)

 

(671,088

)

 

(199,765

)

 

(1,011,411

)

 

(249,747

)

                               

Net Loss

 

(756,611

)

 

(519,534

)

 

(1,415,557

)

 

(1,283,144

)

                               

Statement of Comprehensive Income:

                               

Net Loss

 

(756,611

)

 

(519,534

)

 

(1,415,557

)

 

(1,283,144

)

                               

Other Comprehensive loss

                               

Foreign currency adjustment

 

(12,039

)

   

0

   

(23,689

)

   

0

 
 

(12,039

)

   

0

   

(23,689

)

   

0

 
                               

Total Comprehensive Loss

 

$

(768,650

)

$

(519,534

)

$

(1,439,246

)

$

(1,283,144

)

                               

Net loss per common shares, basic and diluted

 

$

(0.00

)

$

(0.01

)

$

(0.00

)

$

(0.02

)

Weighted average common shares outstanding

   

2, 855,059,171

     

87,316,592

     

2,625,689,405

     

75,919,384

 

 

See notes to interim consolidated financial statements.

 

 
5

 

DOMARK INTERNATIONAL, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

    For the six months ended  
    November 30,     November 30,  
    2014     2013  

CASH FLOWS FROM OPERATING ACTIVITIES    

       

Net Loss

 

$

(1,415,557

)

 

$

(1,283,144

)

               

Adjustments to reconcile net loss to net cash used in operating activities:

               

Depreciation and amortization

   

106,720

     

720

 

Common stock issued for compensation - consultants

   

55,620

     

513,675

 

Common stock issued as compensation

   

-

     

453,825

 

Non cash interest expense

   

344,230

     

88.003

 

Loss (gain) on derivative valuation

   

667,181

     

161,744

 
               

Changes in operating assets and liabilities:

               
               

Prepaid expenses

   

-

     

1

 

Accounts payable and accrued expenses

 

(4,823

)

   

32,303

 

Accounts payable related party

   

7,644

     

-

 
               

Net cash used in operating activities

 

(238,985

)

 

(486,698

)

               

CASH FLOWS FROM INVESTING ACTIVITIES

               

Cash paid for investments

-

 

(134,149

)

Cash paid for loan receivable from consultant

   

-

   

(36,203

)

                

Net cash used in investing activities

   

 -

   

(170,352

)

CASH FLOWS FROM FINANCING ACTIVITIES

               

Proceeds from convertible notes payable

   

138,829

     

442,500

 

Proceeds from loans payable to consultants and stockholders

   

123,367

     

224,499

 

Payments made on loans payable to consultants and stockholders

   

-

   

(10,007

)

Net cash provided by financing activities

   

262,196

     

656,992

 
               

Total Comprehensive Loss - effects of exchange rate changes on cash

 

(23,689

)

   

-

 
               

Net increase (decrease) in cash and cash equivalents

 

(478

)

 

(58

)

CASH BALANCE BEGINNING OF PERIOD

   

460

     

20

 
               

CASH BALANCE/(BANK OVERDRAFT) END OF PERIOD

 

$

(18

)

 

$

(38

)

               

Cash paid for interest

 

$

20,424

    $

-

 

Cash paid for taxes

  $

-

    $

-

 
               

SUPPLEMENTAL SCHEDULE OF NONCASH INVESTING AND FINANCING ACTIVITIES:

               
               

Shares issued for settlement of loans payable to consultants and stockholders

 

$

55,623

   

$

52,500

 

Shares issued for settlement of convertible notes payable

 

$

391,584

   

$

272,362

 

Shares issued for patent acquisition

  $

-

   

$

35,500

 

Shares issued for equity interests in Imagic Ltd

  $

-

   

$

697,500

 

 

 See notes to interim consolidated financial statements.

 

 
6

 

DOMARK INTERNATIONAL, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDING November 30, 2014 AND November 30, 2013

(Unaudited)
 

NOTE 1 – DESCRIPTION OF BUSINESS

 

DOMARK INTERNATIONAL, INC. ("DoMark" or the "Company") was incorporated under the laws of the State of Nevada on March 30, 2006. During 2008 and 2009, the Company acquired several operating businesses. On May 21, 2009, the Company entered into an acquisition agreement (the "Victory Lane Agreement") with Victory Lane Financial Elite, LLC ("Victory Lane") with respect to a real estate lifestyle business known as "Victory Lane" (the "Victory Lane Business"). Shortly thereafter, a dispute arose between the Company and the principals of Victory Lane regarding the representations of the principals of Victory Lane and the Victory Lane Business and the Victory Lane Agreement.

 

On March 5, 2012, the Company entered into an Asset Purchase Agreement with its then controlling shareholder, R. Thomas Kidd, for the sale of the Company’s subsidiary Armada Armada/The Golf Championships and certain assets related thereto. The Company relied upon Accounting Standards Codification (“ASC”) Topic Nos, 8602025 and 8602040 to record the sale. The fair value of the transaction was measured at the fair value of the assets less any liabilities sold.

 

On February 29, 2012, the Company formed a new wholly owned subsidiary, Solarwerks, Inc. in the state of Nevada, for the purposes of entering the business of marketing specialized solar consumer electronics. Solarwerks' current focus is to develop and distribute the SolaPad, a combined cover and charging system for Apple's iPad; and the SolaCase, a combined cover and charging system for all versions of Apple's iPhone. Solarwerks competes in a market that also includes 3D Systems (DDD), Dell (DELL) and Hewlett Packard (HPQ). Solarwerks, Inc. is currently in default with the Nevada Secretary of State.

 

On June 20, 2012, the Company formed a new whollyowned subsidiary, MuscleFoot Inc. in the state of Nevada for the purpose of distributing, marketing, and acting as sales agent for the patented foot care system of Barefoot Science. MuscleFoot Inc. is currently in default with the Nevada Secretary of State.

 

On July 20, 2012, the Company formed a new whollyowned subsidiary, DoMark Canada Inc. in the province of Ontario for the purpose of supporting the Company’s corporate operations based in Toronto, Ontario, Canada.

 

On February 28, 2013, the Company entered into a Memorandum of Understanding to purchase 44% of Zaktek Ltd. (“Zaktek”). Zaktek’s main product is the phonepad+, an Apple Inc. approved tablet device that works with smartphones, including the Apple iPhone® and Samsung Galaxy products to improve functionality including video and gaming abilities.

 

On April 23, 2013, the Company received notification that Zaktek was ending discussions in regards to the definitive purchase agreement with DoMark.

 

On June 11, 2013, the Company then purchased 100% of South Hill Ltd., an English private limited company, which owns approximately 19% of Zaktek.

 

NOTE 2 – GOING CONCERN

 

The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America which contemplate continuation of the Company as a going concern. Furthermore, the Company has inadequate working capital to maintain or develop its operations, and is dependent upon funds from private investors, promissory notes from lenders, and the support of certain stockholders.

 

 
7

 

These factors raise substantial doubt about the ability of the Company to continue as a going concern. These condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty. In this regard, management is planning to raise any necessary additional funds through loans and additional sales of its common stock. There is no assurance that the Company will be successful in raising additional capital.

  

NOTE 3 – BASIS OF PRESENTATION

 

The unaudited consolidated financial statements as of November 30, 2014 and for the six months ended November 30, 2013 have been prepared in accordance with accounting principles generally accepted in the United States for interim consolidated financial information and with instructions to Form 10Q. In the opinion of management, the unaudited consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and reflect all adjustments, which include only normal recurring adjustments, necessary to present fairly the consolidated financial position as of August 31, 2014 and the results of operations and cash flows for the three months ended August 31, 2014 and 2013. The financial data and other information disclosed in these notes to the interim consolidated financial statements related to these periods are unaudited. The results for the six month period November 30, 2014 are not necessarily indicative of the results to be expected for any subsequent quarter of the entire year ending May 31, 2015. The consolidated balance sheet at November 30, 2014 has been derived from the audited consolidated financial statements at that date.

 

Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States have been omitted pursuant to the Securities and Exchange Commission’s rules and regulations. These unaudited consolidated financial statements should be read in conjunction with our audited financial statements and notes thereto for the year ended May 31, 2014 as included in our annual report on Form 10K.

 

NOTE 4 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

RECENT ACCOUNTNG PRONOUNCEMENTS

 

In June 2014, The Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 201410, “Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation” (“ASU 201410”). ASU 201410 removes the financial reporting distinction between development stage entities and other reporting entities and eliminates the requirements for development stage entities to (1) present inceptiontodate information in the statements of income, cash flows, and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. As permitted by ASU 201410, the Company has elected early application of this standard for the accompanying consolidated financial statements for the Quarter ended November 30, 2014 and year ended May 31, 2014. The Company has reviewed other recently issued accounting pronouncements and plans to adopt those that are applicable to it. It does not expect the adoption of these pronouncements to have a material impact on its financial position, results of operations or cash flows.

 

PRINCIPLES OF CONSOLIDATION

 

The accompanying consolidated financial statements represent the consolidated financial position and results of operations of the Company and include the accounts and results of operations of the Company and its subsidiaries. The accompanying consolidated financial statements include the parent entity of DoMark International, Inc. and its wholly owned subsidiaries, Domark Canada, Inc., Solarwerks, Inc., MuscleFoot, Inc. The Company has relied upon the guidance provided by ASC Topic No. 81010153.

 

 
8

 

Foreign Currency Translation and Transaction Gains and Losses

 

We record foreign currency translation adjustments and transaction gains and losses in accordance with SFAS 52, Foreign Currency Translation. For our operations that have a functional currency other than the U.S. dollar, gains and losses resulting from the translation of the functional currency into U.S. dollars for financial statement presentation are not included in determining net loss but are accumulated in the cumulative foreign currency translation adjustment account as a separate component of shareholders’ deficit. The Company and its subsidiaries also have transactions in foreign currencies other than the functional currency. We record transaction gains and losses in our consolidated statements of income related to the recurring measurement and settlement of such transactions. The translation rates as of November 30, 2014 were $1.00 US to $.875 Canadian.

  

USE OF ESTIMATES

 

The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements. These estimates and assumptions also affect the reported amounts of revenues, costs and expenses during the reporting period. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ from those estimates.

 

The primary management estimates included in these condensed consolidated financial statements are the fair value of Company stock tendered in various nonmonetary transactions and the fair value of the derivative liability for convertible notes payable.

 

CASH AND CASH EQUIVALENTS

 

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At November 30, 2014 there weren’t any cash or cash equivalents. At May 31, 2014, cash and cash equivalents consisted only of cash in the bank.

 

LOANS RECEIVABLE CONSULTANT

 

The loan receivable consultants are a short term, less than one year note, due July 15, 2015, noninterest bearing.

 

NET LOSS PER COMMON SHARE

 

Basic net loss per common share is computed by dilutive net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock and potentially dilutive securities (such as convertible notes payable, convertible preferred stock, and warrants) outstanding during the relevant period. Dilutive securities having an antidilutive effect on diluted net loss per common share are excluded from the calculation.

 

For the six months ending November 30, 2014 and 2013, diluted common shares outstanding excluded the following dilutive securities as the effect of their inclusion was antidilutive:

 

 

  Common Shares Equivalent  

 

  Six Months Ended November 30,  

 

  2014     2013  

Convertible notes payable

 

307,459,536

   

2,163,265

 

Series A convertible preferred stock

   

50,000,000

     

50,000,000

 

Warrants

   

850,000

     

850,000

 
               

Total common shares equivalent

   

358,309,536

     

53,013,265

 

 

 
9

 

INTANGIBLE ASSETS

 

Intangible assets are carried at cost less accumulated amortization. Amortization is recorded over the estimated useful lives of the respective assets.

 

IMPAIRMENT OF LONGLIVED ASSETS

 

In accordance with ASC Topic No. 3601040, longlived assets, such as property, plant, and equipment, and purchased intangibles, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Goodwill and other intangible assets are tested for impairment annually. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.

 

STOCKBASED COMPENSATION

 

The Company accounts for share based payments in accordance with ASC Topic No. 718, Compensation Stock Compensation, which requires all sharebased payments to employees, including grants of employee stock options, to be recognized in the financial statements based on the grant date fair value of the award. In accordance with ASC 71810309, Measurement Objective Fair Value at Grant Date, the Company estimates the fair value of the award using a valuation technique. For stock options, the Company uses the BlackScholes option pricing model. The Company believes this model provides the best estimate of fair value due to its ability to incorporate inputs that change over time, such as volatility and interest rates, and to allow for actual exercise behavior of option holders. Compensation cost is recognized over the requisite service period which is generally equal to the vesting period. Upon exercise, shares issued will be newly issued shares from authorized common stock.

 

ASC Topic No. 505, "CompensationStock Compensation", establishes standards for the accounting for transactions in which an entity exchanges its equity instruments to nonemployees for goods or services. Under this method, stock compensation expense includes compensation expense for all stockbased compensation awards granted on or after January 1, 2006, based on the grantdate fair value estimated in accordance with the provisions of ASC 505.

 

RESEARCH AND DEVELOPMENT

 

All research and development expenditures are expensed as incurred.

 

REVENUE RECOGNITION

 

The Company recognizes revenues when persuasive evidence of an arrangement exists, delivery and acceptance has occurred or service has been rendered, the price is fixed or determinable, and collection of the resulting receivable is reasonably assured.

 

 
10

 

NOTE 5 – INVESTMENTS

 

Investments consist of:

 

 

  November 30,     May 31,  

 

  2014     2014  

 

       

Imagic Ltd. 40% equity interest

 

$

1,094,166

   

$

1,094,166

 

Barefoot Science Products & Services Inc. 15% equity interest

   

50,000

     

50,000

 

Total

 

$

1,144,166

   

$

1,144,166

 

 

The cost of the 40% equity interest in Imagic Ltd. at November 30, 2014 consists of:

 

July 22, 2013 issuance of 7,500,000 shares of DoMark common stock to Imagic Ltd.

$

697,500

December 3, 2013 issuance of 8,000,000 shares of DoMark common stock to Meadow Grove Ltd. in exchange for 9% equity interest in Imagic Ltd.

   

96,005

 

Cash payments to or for the benefit of Imagic Ltd.

   

150,661

 

Payments from Foremark Holdings to Imagic Ltd. in exchange for DoMark notes payable to Foremark Holdings

   

150,000

 

Total

 

1,094,166

 

 

Imagic is a privately owned company registered in Gibraltar which owns proprietary product designs for its Digilink and Game Control products. Imagic shares are not quoted or traded on any securities exchange or in any recognized overthe counter market. Imagic is accounted for on the equity method of accounting. The Company consolidates entities that we control. The Company accounts for investments in joint ventures using the equity method of accounting when we exercise significant influence over the venture. If the Company does not exercise significant influence, we account for the investment using the cost method of accounting. Imagic did not have any revenues or expenses for the period ended November 30, 2014.

 

NOTE 6 – LICENSING AGREEMENT WITH WAZZAMBA SA

 

During the three months ended February 28, 2014, the Company executed a Licensing Agreement with Wazzamba SA (the “Licensor”). The agreement provides the Company an exclusive license to use certain technology (which permits thirdparty subscribers to integrate a fully equipped online shop into their websites) in Canada and the United States for an initial term ending July 31, 2015. The agreement provides for the Company to pay the Licensor “Flat Fee” compensation of $ 300,000 in 3 installments of $100,000 each (first installment payable within 5 days of the signing of the agreement, second installment payable on July 1, 2014, and third installment payable on February 1, 2015) plus “Revenue Share” compensation equal to 50% of Net Commissions generated by the Company payable monthly. In the event that the Company does not generate $500,000 in Net Commissions by January 31, 2015, the Licensor has the right to cancel the agreement with one month notice (in which case the third $100,000 installment will no longer be due). With respect to an Extended License Term after July 31, 2015, the agreement provides the Company a right of first refusal to match any offer received by the Licensor from a third party.

 

 
11

 

At November 30, 2014, the Company has a recorded intangible asset for “Licensing Agreement with Wazzamba SA” in the amount of $300,000, and included the liability under the Licenses net of accumulated amortization. Commencing March 1, 2014, the Company will amortize the $300,000 intangible asset on a straight line basis over the remaining 17 months of the Initial Term ending July 31, 2015 (approximately $17,647 per month).

 

On March 27, 2014, the Company paid $25,000 of the first $100,000 “Flat Fee” installment due the Licensor under the agreement. The other $75,000 due is presently past due.

 

Licenses, net of accumulated amortization are as follows:

 

 

  November 30,     May 31,  

 

  2014     2014  

Wazzamba, S.A .

 

$

300,000

    $

300,000

 

Bioharmonics

   

10,000

     

10,000

 

Subtotal

   

310,000

     

310,000

 

Accumulated amortization

 

(162,618

)

 

(60,898

)

Total

 

$

147,382

    $

249,102

 

 

NOTE 7 – NOTE PAYABLE TO BANK

 

In December 2013, the Company entered into a Loan Agreement with a bank located in Maryland. The related Promissory Note in the amount of $180,000 bears interest at a rate at 10% payable monthly, and is due in full on December 31, 2014, and is secured by a 25,000,000 shares of Domark International, Inc (Common Stock Reserve as defined in the Loan Agreement), a Guaranty of Payment from the Company’s chief financial officer and his wife, and certain real property owned by the Company’s chief financial officer and his wife.

 

NOTE 8 – LOANS PAYABLE TO CONSULTANTS AND STOCKHOLDERS

 

Loans payable to consultants and stockholders consist of:

 

 

  November 30,     May 31,  

 

  2014     2014  

Consultant and stockholder

 

$

80,796

   

$

90,402

 

President of DoMark

 

45,850

     

47,500

 

Non Exec Chairman of Domark

   

 -

     

11,875

 

Chairman of Barefoot Science and affiliate

   

21,500

     

21,500

 

Consultant

   

16,097

     

16,097

 

Consultant

   

17,085

     

1,598

 

Total

 

$

181,328

   

$

188,972

 

 

The loans are informal and do not provide for interest or a stated maturity date.

 

 
12

 

NOTE 9 – CONVERTIBLE NOTES PAYABLE

 

At November 30, 2014, the convertible notes payable consisted of;

 

                  Principal     Unamortized     Net Carrying  

Date of Note

 

Noteholder

  Interest Rate      

Maturity Date

  Amount     Debt Discount     Amount  

12/19/13

 

JMJ Financial Inc.

 

10

%

   

12/19/14

   

43,922

(i)     

27,731

     

16,191

 

2/26/14

 

LG Capital Funding, Inc.

   

8

%

   

09/26/14

   

9,467

(a)     

9,467

     

0

 

03/07/14

 

JSJ Investments, Inc

   

12

%

   

10/07/14

   

19,828

(g)     

19,374

     

454

 

03/28/14

 

Redwood Fund, III

   

10

%

   

09/28/14

   

38,409

(f)     

38,409

     

0

 

03/28/14

 

Redwood Management, LLC

   

10

%

   

09/28/14

   

50,000

(g)     

30,191

     

19,809

 

03/28/14

 

Asher Enterprises, Inc

   

8

%

   

09/28/14

   

12,040

(l)    

12,040

     

0

 

04/14/14

 

WHC Capital, Inc

   

12

%

   

10/14/14

   

43,000

(i)     

39,138

     

3,862

 

04/11/14

 

Tonaquint Inc

   

12

%

   

10/11/14

   

48,246

(g)     

28,296

     

19,950

 

04/24/14

 

JSJ Investments, Inc

           

10/24/14

   

50,000

(g)     

30,191

     

19,809

 

05/12/14

 

Iconic Holdings, LLC.

   

10

%

   

11/12/14

   

49,793

(g)     

39,222

     

10,571

 

05/14/14

 

KGM Worldwide, Inc

   

8

%

   

11/14/14

   

32,500

(l)     

22,450

     

10,050

 

06/12/14

 

Adar Bays, LLC.

   

8

%

   

12/12/15

   

52,500

(g)     

40,765

     

11,735

 

06/23/14

 

JMJ Financial, Inc.

   

10

%

   

12/23/14

   

50,000

(i)     

38,568

     

11,432

 

07/03/14

 

LG Capital, Inc

   

8

%

   

01/03/15

   

36,750

(a)     

27,789

     

8,961

 

07/22/14

 

Redwood Fund, III

   

10

%

   

01/22/15

   

100,082

(g)    

93,257

     

6,825

 

8/14/14

 

KBM Worldwide, Inc

   

8

%

   

2/14/15

   

27,500

(i)     

27,156

     

344

 

10/8//14

 

LG Capital Funding, Inc.

   

8

%

   

04/8/15

   

3,000

(a)     

2,949

     

51

 

Totals

                   

$

667,037

   

$

526,993

   

$

140,044

 

 

Legend

 

(a)

At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.081 or 50% of the average of the three lowest closing prices during the 10 trading days prior to the notice of conversion.

 

 

(b)

At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.085 or 60% of the lowest closing price during the 25 trading days prior to the notice of conversion.

 

 

(c)

At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.08 or 50% of the lowest closing price during the 10 trading days prior to the notice of conversion.

 

 

(d)

At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.0725 or 34% of the lowest closing price during the 20 trading days prior to the notice of conversion.

 

 

(e)

At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 55% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion.

 

 

(f)

At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.00929 or 50% of the average of the three lowest trading prices during the 10 trading days prior to the notice of conversion.

 

 

(g)

At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 25% of the lowest trading price during the 20 trading days prior to the notice of conversion.

 

 
13

 

(h)

At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 58% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion.

 

 

(i)

At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 40% of the lowest closing price during the 25 trading days prior to the notice of conversion.

 

 

(j)

At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 40% of the lowest closing price during the 20 trading days prior to the notice of conversion.

 

 

(k)

At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 58% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion.

 

 

(l)

At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 49% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion.

 

NOTE 10 – STOCKHOLDERS’ EQUITY

 

Series A Convertible Preferred Stock

 

Each share of Series A Convertible Preferred Stock has 1,000 voting rights and is convertible into 1,000 shares of common stock.

 

Common Stock Issuances

 

On September 4, 2014, the Company issued 70,000,000 shares of common stock for JMJ Financial, Inc. in satisfaction of $14,040 principal amount of convertible notes payable.

 

On September 4, 2014, the Company issued 170,760,000 shares of common stock for Iconic Holdings, LLC in satisfaction of $8,538 of principal amount of convertible notes payable.

 

On September 12, 2014, the Company issued 78,759,945 shares of common stock for LG Capital, Inc. in satisfaction of $3,938 of principal amount of convertible notes payable.

 

On September 19, 2014, the Company issued 170,760,000 shares of common stock for Iconic Holdings, LLC in satisfaction of $8,538 of principal amount of convertible notes payable

 

On September 19, 2014, the Company issued 93,841,481 shares of common stock for JSJ Investments, Inc. in satisfaction of $4,692 of principal amount of convertible notes payable.

 

On September 19, 2014, the Company issued 100,271,400 shares of common stock for LG Capital, Inc. in satisfaction of $5,014 of principal amount of convertible notes payable.

 

On September 19, 2014, the Company issued 100,000,000 shares of common stock for JMJ Financial, Inc. in satisfaction of $12,000 of principal amount of convertible notes payable.

 

On September 23, 2014, the Company issued 98,439,714 shares of common stock for JSJ Investments, Inc. in satisfaction of $4,922 of principal amount of convertible notes payable.

 

On October 1, 2014, the Company issued 103,263,260 shares of common stock for JSJ Investments, Inc. in satisfaction of $2,582 of principal amount of convertible notes payable.

 

 
14

 

On October 1, 2014, the Company issued 265,320,000 shares of common stock for Iconic Holdings, LLC. in satisfaction of $6,633 of principal amount of convertible notes payable.

 

On October 1, 2014, the Company issued 105,000,000 shares of common stock for JMJ Financial, Inc. in satisfaction of $6,300 of principal amount of convertible notes payable.

 

On October 1, 2014, the Company issued 133,984,700 shares of common stock for Redwood Fund, III in satisfaction of $2,680 of principal amount of convertible notes payable.

 

On October 1, 2014, the Company issued 141,004,800 shares of common stock to Redwood Fund III, Inc. in satisfaction of $2,680 of principal amount of convertible notes payable.

 

On October 16, 2014, the Company issued 64,500,000 shares of common stock to KBM Worldwide, Inc., Inc. in satisfaction of $3,225 principal amount of convertible notes payable.

 

On October 16, 2014, the Company issued 87,800,000 shares of common stock to KBM Worldwide, Inc.in satisfaction of $4,390 principal amount of convertible notes payable..

 

On October 16, 2014, the Company issued 92,480,000 shares of common stock to WHC Captial, Inc. in satisfaction of $4,624 principal amount of convertible notes payable.

 

On October 16, 2014, the Company issued 175,750,000 shares of common stock to Tonaquint, Inc. in satisfaction of $4,393 principal amount of convertible notes payable.

 

On October 20, 2014, the Company issued 152,300,000 shares of common stock to KBM Worldwide, Inc. in satisfaction of $7,615 principal amount of convertible notes payable.

 

On October 20, 2014, the Company issued 148,392,800 shares of common stock to Redwood Fund, III, Inc. in satisfaction of $2,968 principal amount of convertible notes payable.

 

On October 30,, 2014, the Company issued 184,359,000 shares of common stock to LG Capital Funding, Inc. in satisfaction of $3,687 principal amount of convertible notes payable.

 

On November 10, 2014, the Company issued 152,300,000 shares of common stock to KBM Worldwide, Inc. in satisfaction of $7,615 principal amount of convertible notes payable.

 

On November 10, 2014 the Company issued 157,500,000 shares of common stock Tonaquint, Inc in satisfaction of $3,937 principal amount of convertible notes payable..

 

On November 11, 2014, the Company issued 324,186,800 shares of common stock to Iconic Holdings, LLC. in satisfaction of $8,105 principal amount of convertible notes payable.

 

On November 19, 2014, the Company issued 107,520,000 shares of common stock to WHC Capital Inc. in satisfaction of $5,376 principal amount of convertible notes payable.

 

On November 19, 2014, the Company issued 156,167,800 shares of common stock to KBM Worldwide, Inc in satisfaction of $7,615 principal amount of convertible noted payable.

 

On November 19, 2014,, the Company issued 222,151,000 shares of common stock to LG Capital Funding, Inc. in satisfaction of $4,443 principal amount of convertible notes payable.

 

On November 20, 2014, the Company issued 212,530,662 shares of common stock to Iconic Holdings, LLC in satisfaction of $5,207 principal amount of loan payable.

 

 
15

 

Warrants to Purchase Common Stock

 

A summary of warrant activity for the six months ending November 30, 2014 and for the year ended May 31, 2014 are as follows:

 

 

  Weighted Average      

 

  Number of     Exercise  

 

  Warrants     Price  

Outstanding at May 31, 2012

  -     $    

Granted

 

850,000

   

0.42

 

Exercised

   

 

     

 

 

Cancelled

   

 

     

 

 
               

Outstanding at May 31, 2013

   

850,000

     

0.42

 

Granted

   

 

     

 

 

Exercised

   

 

     

 

 

Cancelled

   

 

     

 

 

Outstanding at November 30, 2014

   

850,000

    $

0.42

 

 

Warrants outstanding at November 30, 2014 consist of:

  

Date Granted

 

 Number Outstanding  

Exercise price  

Expiration Date 

May 25, 2012

 

100,000

 

$

1.00

 

May 25, 2015

June 12, 2012

 

150,000

 

$

1.00

 

June 12, 2015

June 26, 2012

 

100,000

 

$

1.00

 

June 26, 2015

January 1, 2012

 

500,000

 

$

0.01

 

January 1, 2015

         

Totals

 

850,000

         

 

NOTE 11 – FAIR VALUE MEASUREMENTS AND DERIVATIVE LIABILIITY

 

The Company evaluates all of it financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then revalued at each reporting ate, with changes in the fair value reported as charges or credits to income. For optionbased derivative financial instruments, the Companyuses the BlackScholes optionpricing model to value the derivative instruments at inception and subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is reassessed at the end of each reporting period derivative instrument liabilities are classified in the balance sheet as current or noncurrent based on whether or not netcash settlement of the derivative instrument could be required within 12 months of the balance sheet date.

 

During the period ended November 30, 2014 the Company entered into several convertible note agreements. The conversion option and the outstanding common stock warrants on that date which were tainted by the convertible note were classified as derivative liabilities at their fair value on the date of issuance.

 

 
16

 

Under ASC815 the conversion options embedded in the notes payable described in Note 9 require liability classification because they do not contain an explicit limit to the number of shares that could be issued upon settlement.

 

As defined in FASB ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilized the market data of similar entities in its industry or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. The Company classifies fair value balances based on the observability of those inputs. FASB ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement).

 

The three levels of the fair value hierarchy are as follows:

 

Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchangetraded derivatives, marketable securities and listed equities.

 

Level 2 – Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date.

 

Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.

 

Derivative liability — the Company’s derivative liability is classified within Level 3 of the fair value hierarchy.

 

The Company uses the Black Scholes Option Pricing Model to value its option based derivatives based upon the following assumptions: dividend yield of 0%, volatility of stock price =100%, risk free rate varying from 8 to 12 % and an expected term equal to the remaining conversion of the note.

 

The following table sets forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value as at November 30, 2014.

 

Recurring Fair Value Measurements   Level 1     Level 2     Level 3     Total  
           

 

     

 

 

LIABILITIES:

   

 

     

 

     

 

     

 

 

Derivative liability November 30, 2014

   

 -

     

 -

   

2,416,159

   

2,416,159

 

 

 

 

 

 

Derivative liability May 31, 2014

   

 -

     

 -

     

1,748,982

     

1,748,982

 

 

 
17

 

NOTE 12 – COMMITMENTS AND CONTINGENCIES

 

License Agreements

 

On February 29, 2012, the Company entered into a Memorandum of Agreement with Xiamen Taiyang Neng Gongsi and Michael Franklin. For and in consideration of the payment of an initial license fee of $10,000, and for the future payment of royalties of $5.00 per SolaPad unit sold, Xiamen granted an exclusive worldwide license and joint patent rights to the Company for a solar charging case for IPAD, including IPAD 3. The license under the Agreement expires on December 31, 2018.

 

On April 19, 2013, our subsidiary DoMark Canada Inc. executed an agreement with Bioharmonics Technologies Cop. (“Bioharmoniecs”). The agreement provided for the acquisition of certain inventions and related patents and patent applications in exchange for 500,000 shares of DoMark common stock (which was delivered April 19, 2013) and $30,000 cash payable no later than October 17, 2013 (which was satisfied through the delivery of an additional 500,000 shares of DoMark common stock to Bioharmonics on August 15, 2013). The agreement also provides for a royalty obligation payable quarterly to Bioharmonics equal to 10% of the wholesale price for each unit using infrared and solar charging.

 

In January 2014, the Company executed a Licensing Agreement with Wazzamba SA. See Note 6.

 

Employment Agreements

 

On May 25, 2012, the Company entered into an employment agreement with its President, R. Brentwood Strasler, for an indefinite period or until terminated. Mr. Strasler is entitled to an annual salary of $150,000 USD and 100,000 stock purchase warrants exercisable to purchase shares of common stock of the Company at $1.00 per share. The warrants are exercisable for a three year period and can be vested quarterly on a pro rata basis over twelve months from the date of issue. Additionally, Mr. Strasler is to be enrolled in a long term Executive Option Plan and is entitled to term life insurance in the face amount of $2,500,000, payable to the beneficiary designated by Mr. Strasler.

 

On June 15, 2012, the Company entered into an employment agreement with its Chief Executive Officer Andrew Ritchie, for an indefinite period or until terminated. Mr. Ritchie is entitled to an annual salary of $240,000 USD and 150,000 stock purchase warrants exercisable to purchase shares of common stock of the Company at $1.00 per share. The warrants are exercisable for a three year period and can be vested quarterly on a pro rata basis over twelve months from the date of issue. Additionally, Mr. Ritchie is to be enrolled in a long term Executive Option Plan and is entitled to term life insurance in the face amount of $2,500,000, payable to the beneficiary designated by Mr. Richie.

 

Lease Agreement

 

On August 1, 2013, the Company entered into an office lease in Toronto, Ontario, Canada for a five year period. At November 30, 2014, the future lease commitments on this lease for the years ended May 31, are as follows, and are in U.S. dollars:

 

2015

$

22,528

 

2016

 

47,616

 

2017

 

47,616

 

2018

 

47,616

 

Thereafter

 

7,936

 

   

Total

$

173,312

 

  

NOTE 13 – SUBSEQUENT EVENT

 

In January 2015, the Company entered into a joint venture agreement with Mobil Lads, Corp, to acquire 75% of Simbadeals North American licensing rights, for $700,000 value of Mobile Lads Corp common stock and $225,000 in cash. The cash will be used by Domark to pay off the existing licensing responsibilities to Wazzamba ( the program developer of Simbadeals). Mobil Lads Corp will manage the future of Simbadeals and will be fully responsible for all future funding of the operation. Domark will retain the 25% interest in the Joint Venture.

 

 
18

 

ITEM 2 MANAGEMENT DISCUSSION AND ANALYSIS OF THE CONSOLIDATED FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following is management's discussion and analysis of certain significant factors that have affected our condensed consolidated financial position and operating results during the periods included in the accompanying condensed consolidated financial statements, as well as information relating to the current plans of our management. This report includes forwardlooking statements. Generally, the words "believes", "anticipates", "may", "will", "should", "expect", "intend", "estimate", "continue", and similar expressions or the negative thereof or comparable terminology are intended to identify forwardlooking statements.

 

Such statements are subject to certain risks and uncertainties, including the matters set forth in this report or other reports or documents we file with the Securities and Exchange Commission from time to time, which could cause actual results or outcomes to differ materially from those projected. Undue reliance should not be placed on these forwardlooking statements, which speak only as of the date hereof. We undertake no obligation to update these forwardlooking statements.

 

The following discussion and analysis should be read in conjunction with our consolidated financial statements and the related notes thereto and other financial information contained elsewhere in this Form 10Q.

 

RECENT DEVELOPMENTS

 

The main operations of the Company have been to search, negotiate and acquire ownership interests in companies with products at an advanced stage of their development or products already in production.

 

In December 2013, the Company increased its equity interest in Imagic Ltd. to 40%. Imagic is a company registered in Gibraltar which owns proprietary product designs for its Digilink and Game Control products.

 

In January 2014, the Company acquired United States and Canada marketing rights to certain online shop technology pursuant to a Licensing Agreement with Wazzamba SA.

 

On February 24, 2014, the Company increased the number of authorized shares of common stock to 900,000,000 shares.

 

On August 11, 2014, the Company increased the number of authorized shares of common stock to 7,500,000,000.

 

On December 15, 2014, R. Brent Strasler (non Exec. Chariman) tendered his resignation to the Company, mutually agreed upon by the President/CEO.

 

In January 2015, the Company entered into a joint venture agreement with Mobil Lads, Corp, to acquire 75% of Simbadeals North American licensing rights, for $700,000 value of Mobile Lads Corp common stock and $225,000 in cash. The cash will be used by Domark to pay off the existing licensing responsibilities to Wazzamba (the program developer of Simbadeals). Mobil Lads Corp will manage the future of Simbadeals and will be fully responsible for all future funding of the operation. Domark will retain the 25% interest in the Joint Venture.

 

LIQUIDITY AND CAPITAL RESOURCES

 

Our operating requirements have been funded primarily through financing facilities, sales of our common stock, and loans from shareholders and 3rd party financiers. Currently, the Company's cash flows do not adequately support the operating expenses of the Company. We received $0 in the six months ended November 30, 2014 from the sale of our common stock. The Company will continue to require financing from loans and notes payable until such time as our business has generated income sufficient to carry our operating costs.

 

Cash used by operating activities for the six month period ended November 30, 2014 was $238,985 compared to $486,698 for the same period in 2013. Stockbased compensation for the six month period ended November 30, 2014 was $55,620 as compared to $513,675 for the six month period ended November 30, 2013.

 

Cash used in investing activities was $0 for the six month period ended November 30, 2014 compared to $170,352 for the six month period ended November 30, 2013. Cash provided by financing activities was $262,196 for the six month period ended November 30, 2014 versus $656,992 for the six month period ended November 30, 2013. Financing activities consisted of cash received from related parties and promissory convertible notes payable.

  

OTHER CONSIDERATIONS

 

There are numerous factors that affect the Company's business and the results of its consolidated operations. Sources of these factors include general economic and business conditions, federal and state regulation of business activities, the level of demand for services, the level and intensity of competition, and our ability to continue to improve our infrastructure, including personnel and systems, to keep pace with our anticipated rapid growth in the development of our business.

 

 
19

 

RESULTS OF CONDENSED CONSOLIDATED OPERATIONS

 

SIX MONTHS ENDED NOVEMBER 30, 2014 VS. NOVEMBER 30, 2013

 

The Company did not have any revenues for the six months ending November 30, 2014, and November 30, 2013.

 

Total general and administrative expenses for the six months ending November 30, 2014 were $241,806 compared to $519,002 for the same six month period in 2013. The decrease is primarily due to the lesser consulting amounts for the period ending November 30, 2014.

 

The net loss for the six months ending November 30, 2014 amounted to $1,415,557 for a net loss per share of $0.00, vs. a net loss of $1,283,144 and a net loss per share of $0.02 for the same six month period ending in 2013. The decrease was primarily due to a reduced consulting fees.

 

ITEM 3 QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable to smaller reporting companies.

 

ITEM 4 CONTROLS AND PROCEDURES

 

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

 

Our management team, under the supervision and with the participation of our principal executive officer and our principal financial officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as such term is defined under Rule 13a15(e) promulgated under the Securities Exchange Act of 1934, as amended ("Exchange Act"), as of the last day of the fiscal period covered by this report, November 30, 2013. The term disclosure controls and procedures means our controls and other procedures that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to management, including our principal executive and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Based on this evaluation, our principal executive officer and our principal financial officer concluded that our disclosure controls and procedures were not effective as of November 30, 2014. Management is working on hiring other responsibilities to add some internal control procedures.

 

Our principal executive officer and our principal financial officer are responsible for establishing and maintaining adequate internal controls over financial reporting, as such term is defined in Exchange Act Rules 13a15(f). Management is required to base its assessment of the effectiveness of our internal control over financial reporting on a suitable, recognized control framework, such as the framework developed by the Committee of Sponsoring Organizations ("COSO"). The COSO framework, published in INTERNAL CONTROLINTEGRATED FRAMEWORK, is known as the COSO Report. Our principal executive officer and our principal financial officer have chosen the COSO framework on which to base its assessment. Based on this evaluation, our management concluded that our internal control over financial reporting was not effective as of November 30, 2014.

 

There weren't any changes in our internal control over financial reporting that occurred during the period ended November 30, 2014 that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting. Controls are being put in place for daily operations which will allow for controlled cash management and oversite.

 

It should be noted that any system of controls, however well designed and operated, can provide only reasonable and not absolute assurance that the objectives of the system are met. In addition, the design of any control system is based in part upon certain assumptions about the likelihood of certain events. Because of these and other inherent limitations of control systems, there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote.

 

Management is aware that there is a lack of segregation of duties at the Company due to the small number of employees dealing with general administrative and financial matters. However, at this time management has decided that considering the abilities of the employees now involved and the control procedures in place, the risks associated with such lack of segregation are low and the potential benefits of adding employees to clearly segregate duties do not justify the substantial expenses associated with such increases. Management will periodically reevaluate this situation.

 

 
20

 

PART II OTHER INFORMATION

 

ITEM 1 LEGAL PROCEEDINGS

 

On May 21, 2009, the Company entered into an Agreement for the Exchange of Common Stock (the "Victory Lane Agreement") with Victory Lane Financial Elite, LLC ("Victory Lane") with respect to a real estate lifestyle business known as Victory Lane (the "Victory Lane Business") pursuant to which the Company intended to purchase the Victory Lane Business. Shortly thereafter, a dispute arose between the Company and Victory Lane regarding alleged misrepresentations made by Victory Lane in connection with the Victory Lane Agreement.

 

In August, 2009, Victory Lane Financial Elite, LLC, Legacy Development, LLC and Patrick Costello filed suit in the Superior Court of Tattnall County, Georgia (Civ. No. 2009V381JW) against the Company, R. Thomas Kidd and various officers and directors of the Company, alleging that the Company was in breach of the Victory Lane Agreement and that the Company and certain of the individual defendants had committed various torts against the plaintiffs and that certain of the individual defendants had violated various fiduciary and other duties owed to the plaintiffs in connection with the Victory Lane Agreement and the handling of the Victory Lane Business (the "VLFE Case"). The plaintiffs sought a declaratory judgment to the effect that the Victory Lane Agreement had not been executed, as well as money damages from the Company and the individual defendants. The Company and Mr. Kidd have answered the Complaint, denying any liability for the plaintiff's claims and have asserted various counterclaims including fraud and other torts. In July 2010 the court dismissed all of the individual defendants, other than R. Thomas Kidd, in response to a motion to dismiss for lack of jurisdiction. The case has since been stayed.

 

In December, 2009, AHIFO21, LLC filed a lawsuit in the Superior Court of Tattnall County, Georgia (Civ. No. 2009V672JS) against Victory Lane, LLC, Patrick J. Costello and Stephen Brown (the "Victory Lane Defendants") alleging that the Victory Lane Defendants owe the plaintiff more than $7,740,000 in respect of one or more loans made by the plaintiff to certain Victory Lane Defendants in connection with the Victory Lane Business (the "AHIFO Case"). In February 2010, the Victory Lane Defendants filed a Third Party Complaint against the Company and R. Thomas Kidd, claiming that the Company and Mr. Kidd should be liable for any amounts the Victory Lane Defendants are required to pay to the plaintiff in this case. The Company and Mr. Kidd have answered the Complaint, denying any liability for the plaintiff's claims and Mr. Kidd has asserted various counterclaims including fraud and other torts. The Company and Mr. Kidd filed a motion to dismiss the Third Party Complaint, but the entire case was subsequently stayed.

 

Because each of the VLFE Case and the AHIFO Case have been stayed and because discovery in those cases is not complete, the Company has determined that the probability of any loss is remote and that the amount of any damages, if any were determined adverse to the Company, would not be reasonably estimable. The Company believes that it has meritorious claims against the opposing parties with respect to the Victory Lane Agreement and that the claims asserted against it are not meritorious. The Company intends to defend itself vigorously.

 

ITEM 1A RISK FACTORS

 

Not required.

 

ITEM 2 UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3 DEFAULTS UPON SENIOR SECURITIES

 

There were no defaults upon senior securities during the interim period ended November 30, 2014.

 

ITEM 4 MINE SAFETY DISCLOSURE

 

None.

 

ITEM 5 OTHER INFORMATION

 

None.

 

 
21

 

ITEM 6 EXHIBITS

 

Exhibit No.

Document Description

31.1

 

Certification of CEO Pursuant to 18 U.S.C. Section 1350, Pursuant to Section 302 of the SarbanesOxley Act of 2002.

31.2

 

Certification of CFO Pursuant to 18 U.S.C. Section 1350, Pursuant to Section 302 of the SarbanesOxley Act of 2002.

32.1*

 

Certification of CEO Pursuant to 18 U.S.C. Section 1350, Pursuant to Section 906 of the SarbanesOxley act of 2002.

32.2*

 

Certification of CFO Pursuant to 18 U.S.C. Section 1350, Pursuant to Section 906 of the SarbanesOxley act of 2002.

101

 

Interactive data files pursuant to Rule 405 of Regulation ST.

______________

* This exhibit shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 of the Securities Exchange Act of 1934, whether made before or after the date hereof and irrespective of any general incorporation language in any filings.

 

 
22

 

SIGNATURES

 

In accordance with Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, there unto duly authorized.

 

 

DOMARK INTERNATIONAL, INC.

REGISTRANT

 

   

Date: January 20, 2015

By:

/s/ Andrew Ritchie

 

 

Andrew Ritchie

 

 

Chief Executive Officer/President

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the undersigned on behalf of the registrant and in the capacities indicated on the 20th day of January 2015.

 

By: /s/ Thomas Crompton  
   

Thomas Crompton 

 
   

Chief Financial Officer

 

 

 

23